<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We investigated the potential role of defective DNA-mismatch repair (MMR) as a mediator of leukemogenic susceptibility in patients with therapy-related <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> (t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and <z:hpo ids='HP_0001909'>leukemia</z:hpo> (t-leuk) </plain></SENT>
<SENT sid="1" pm="."><plain>Thirty-seven individuals with t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/t-leuk were analyzed for microsatellite instability (MSI), the hallmark of defective DNA-MMR </plain></SENT>
<SENT sid="2" pm="."><plain>Using standardized international criteria, 5/37 (14%) patients displayed high MSI, whereas 3 other patients had low MSI (8%) </plain></SENT>
<SENT sid="3" pm="."><plain>To determine the stage at which MSI had developed, we analyzed the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> of 12 patients </plain></SENT>
<SENT sid="4" pm="."><plain>Three of 4 patients with high MSI t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/t-leuk also had microsatellite unstable <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Conversely, MSI was not detected in any primary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> of patients with low MSI or microsatellite stable t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/t-leuk (P = 0.0182) </plain></SENT>
<SENT sid="6" pm="."><plain>In the high MSI group, we further investigated genes targeted by defective DNA-MMR (BAX, TGFBRII, IGFIIR, Caspase-5, APC, PTEN, E2F4, MBD4, MSH6, and MSH3) in both <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> and t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/t-leuk </plain></SENT>
<SENT sid="7" pm="."><plain>However, no mutation was found in any gene </plain></SENT>
<SENT sid="8" pm="."><plain>The significant association of MSI in t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/t-leuk and corresponding <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> suggests that defective DNA-MMR confers leukemogenic susceptibility to this cohort of patients </plain></SENT>
</text></document>